Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?

por Islam, Hashim, Chamberlain, Thomas C., Mui, Alice L., Little, Jonathan P.
Publicado 2021

Interleukin-10 contributes to PGE(2) signalling through upregulation of EP4 via SHIP1 and STAT3

por Samiea, Abrar, Yoon, Jeff S. J., Cheung, Sylvia T., Chamberlain, Thomas C., Mui, Alice L. -F.
Publicado 2020

Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells

por Samiea, Abrar, Yoon, Jeff S. J., Ong, Christopher J., Zoubeidi, Amina, Chamberlain, Thomas C., Mui, Alice L.-F.
Publicado 2020

Interleukin-10 control of pre-miR155 maturation involves CELF2

por Yoon, Jeff S. J., Wu, Mike K., Zhu, Tian Hao, Zhao, Helen, Cheung, Sylvia T., Chamberlain, Thomas C., Mui, Alice L-F.
Publicado 2020

Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-inflammatory Effects through SHIP1/STAT3 Complexes

por Chamberlain, Thomas C., Cheung, Sylvia T., Yoon, Jeff S.J., Ming-Lum, Andrew, Gardill, Bernd R., Shakibakho, Soroush, Dzananovic, Edis, Ban, Fuqiang, Samiea, Abrar, Jawanda, Kamaldeep, Priatel, John, Krystal, Gerald, Ong, Christopher J., Cherkasov, Artem, Andersen, Raymond J., McKenna, Sean A., Van Petegem, Filip, Mui, Alice L-F.
Publicado 2020